Leukocare secures USD17.5m in funding round led by Petrichor
Leukocare AG, a biotechnology company specialised in the field of biopharmaceutical formulation development, has closed a USD17.5 million (EUR 14.6 million) financing, led by Petrichor Healthcare Capital Management, with participation from existing Leukocare shareholders. The financing consists of a USD15 million convertible loan and a USD2.5 million equity investment from